Live Breaking News & Updates on லாரன்ஸ் ரீட்

Stay updated with breaking news from லாரன்ஸ் ரீட். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Decibel Therapeutics Appoints Dr. William H. Carson as Chairman of the Board of DirectorsDistinguished biopharma executive brings over 20 years of leadership in life sciences


®, the first FDA-approved digital medicine.
Bill currently serves as Chairman of the Board of Directors of OPDC and is also the Chairman of the Board of the Sozosei Foundation, a newly established Otsuka charitable organization focused on decriminalization of mental illness. He serves on the boards of Excision BioTherapeutics, Saama and Annexon Biosciences and is Trustee of the non-profit Internet2. He is Board Chair Emeritus of the Sphinx Organization, which advocates for parity and inclusion in the arts.
“Bill is an eminent figure in the biopharmaceutical community with a proven track record of advancing therapies through clinical development, regulatory approval and commercialization. His appointment demonstrates our ambition to establish Decibel at the forefront of innovation in treatments to restore and improve hearing and balance,” said Laurence Reid, Ph.D., Chief Executive Officer. “Bill is passionate about delivering life-changing therapies in areas of unmet ....

United States , Julie Seidel , Abilify Mycite , Annexon Biosciences , Laurence Reid , Chris Railey , Abilify Maintena , American Psychiatric Association , Stern Investor Relations Inc , Leadership Council , Sphinx Organization , Sozosei Foundation , Department Of Psychiatry , Case Western Reserve University School Of Medicine , University Of South Carolina , National Medical Association , Harvard College , Otsuka Pharmaceutical Development Commercialization Inc , Tufts University School Of Medicine , Behavioral Sciences , Otsuka Pharmaceutical Development , Board Chair Emeritus , Chief Executive , Case Western Reserve University School , Tufts University School , Distinguished Fellow ,

Decibel Therapeutics Appoints - GuruFocus.com


®, the first FDA-approved digital medicine.
Bill currently serves as Chairman of the Board of Directors of OPDC and is also the Chairman of the Board of the Sozosei Foundation, a newly established Otsuka charitable organization focused on decriminalization of mental illness. He serves on the boards of Excision BioTherapeutics, Saama and Annexon Biosciences and is Trustee of the non-profit Internet2. He is Board Chair Emeritus of the Sphinx Organization, which advocates for parity and inclusion in the arts.
“Bill is an eminent figure in the biopharmaceutical community with a proven track record of advancing therapies through clinical development, regulatory approval and commercialization. His appointment demonstrates our ambition to establish Decibel at the forefront of innovation in treatments to restore and improve hearing and balance,” said Laurence Reid, Ph.D., Chief Executive Officer. “Bill is passionate about delivering life-changing therapies in areas of unmet ....

United States , Julie Seidel , Abilify Mycite , Annexon Biosciences , Laurence Reid , Chris Railey , Abilify Maintena , American Psychiatric Association , Stern Investor Relations Inc , Leadership Council , Sphinx Organization , Sozosei Foundation , Department Of Psychiatry , Case Western Reserve University School Of Medicine , University Of South Carolina , National Medical Association , Harvard College , Otsuka Pharmaceutical Development Commercialization Inc , Tufts University School Of Medicine , Behavioral Sciences , Otsuka Pharmaceutical Development , Board Chair Emeritus , Chief Executive , Case Western Reserve University School , Tufts University School , Distinguished Fellow ,